Doximity Insider Buy: CEO and CFO Stack Shares, Boosting Confidence Amid Market Dip

Insider Activity Spotlight: Doximity Inc. and Wampler Kira Scherer

Buy‑to‑Hold Amid a Volatile Market On February 2, 2026, Wampler Kira Scherer added 2,000 shares of Class A common stock to her holdings, raising her total stake to 21,839 shares. The purchase occurred at a price of $35.25, just above the closing price of $34.85, in a day when the stock slipped 8.99 % for the week and 22.85 % for the month. Despite the broader sell‑off, Scherer’s action signals confidence in Doximity’s long‑term prospects. The transaction was part of a Rule 10b‑5b‑1 trading plan, suggesting that it was pre‑planned and not driven by a sudden market event.

Implications for Investors Scherer’s purchase comes at a time when sentiment around DOCS is unusually bullish (+36 on a sentiment scale) and social‑media buzz is high (602 % above average). For investors, this juxtaposition of a strong insider buy against a backdrop of market weakness and heightened chatter could be interpreted as a “long‑only” bet in a crowded trade. It also adds to a pattern of disciplined, scheduled transactions rather than opportunistic trades, which may reassure risk‑averse shareholders.

Patterns in Scherer’s Trading History Reviewing Scherer’s past filings reveals a consistent strategy: regular buys and sells of both Class A and Class B shares, coupled with the exercise of a large block of stock options (often 7,000–10,000 options). She typically sells options at zero cost, converting them into cash, while her share purchases are spread over several months. The most recent sell of 2,000 Class B shares on February 2 was part of a conversion to Class A shares, a common mechanism for insiders to increase voting power without diluting equity. Her net holdings have fluctuated between 16,618 and 23,618 shares over the past year, indicating a moderate level of equity exposure.

Company‑Wide Insider Activity Scherer’s moves are mirrored by other executives, notably CFO Bryson Anna, who bought over 20,000 shares in early November 2025, and CEO Tangney Jeffrey, who purchased a record 168,154 shares in April 2025. The overall insider buying trend suggests that senior management believes the stock is undervalued, especially given the current 52‑week low of $34.31 and a price‑to‑earnings ratio of 28.7. This optimism is tempered by the recent 39.5 % yearly decline, underscoring the need for caution.

What This Means for the Future Doximity’s core platform—an online collaborative tool for physicians—remains a high‑growth niche within health‑tech. The insider confidence, coupled with a rising buzz index, could foreshadow a rebound once the broader market corrects. However, the company’s valuation still sits above its long‑term earnings averages, and the recent sell‑off indicates lingering concerns about competitive pressure and monetization. Investors should monitor upcoming quarterly earnings, any changes to the 10b‑5b‑1 trading plan, and the company’s progress on expanding its member base. For those holding DOCS, Scherer’s disciplined buying may be a positive signal; for new investors, a cautious approach that aligns with the company’s long‑term roadmap is advisable.